Comparison

Tosylate-DPA-714 European Partner

Item no. HY-400882-5mg
Manufacturer MedChem Express
CASRN 958233-17-5
Amount 5 mg
Quantity options 100 mg 10 mg 25 mg 50 mg 5 mg
Specific against other
Purity 97.01
Citations [1]James ML, et al. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization. J Nucl Med. 2008 May;49(5):814-22.
Smiles O=C(CC1=C(N=C(C)C=C2C)N2N=C1C3=CC=C(OCCOS(=O)(C4=CC=C(C)C=C4)=O)C=C3)N(CC)CC
Shipping condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Targets
Drug Derivative
Shipping Temperature
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight
550.67
Product Description
Tosylate-DPA-714 (compound 2) is a DPA-714 (HY-122607) tosylate analog. Tosylate-DPA-714 is a precursor for 18 F-DPA-714. DPA-714 is a translocator protein (TSPO)-specific ligand [1] .
Manufacturer - Research Area
Inflammation/Immunology; Neurological Disease
Manufacturer - Pathway
Others
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close